Cargando…
Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy
SIMPLE SUMMARY: Hepatoblastoma (HBL) is a rare hepatic malignancy occurring mainly in early childhood. Although recently developed treatment regimens have improved prognosis, many refractory cases still exist, and the anticancer drug cis-diamminedichloroplatinum—cisplatin—primarily used in HBL treat...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562177/ https://www.ncbi.nlm.nih.gov/pubmed/36230656 http://dx.doi.org/10.3390/cancers14194732 |